| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.03 |